These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6509797)

  • 1. Polymorphonuclear leucocyte locomotion and aggregation in patients with alcoholic liver disease.
    Rajkovic IA; Yousif-Kadaru AG; Wyke RJ; Williams R
    Clin Exp Immunol; 1984 Dec; 58(3):654-62. PubMed ID: 6509797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects of serum chemoattraction and polymorphonuclear leucocyte movement in patients with primary hepatocellular carcinoma.
    Yousif-Kadaru AG; Wyke RJ; Rajkovic IA; Eddleston AL; Williams R
    Clin Exp Immunol; 1982 Aug; 49(2):467-73. PubMed ID: 6290116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum stimulatory activity and polymorphonuclear leucocyte movement in patients with fulminant hepatic failure.
    Wyke RJ; Yousif-Kadaru AG; Rajkovic IA; Eddleston AL; Williams R
    Clin Exp Immunol; 1982 Nov; 50(2):442-9. PubMed ID: 7151333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
    Perez HD; Lipton M; Goldstein IM
    J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired opsonization by serum from patients with chronic liver disease.
    Wyke RJ; Rajkovic IA; Williams R
    Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of filter-bound IgA in inhibiting polymorphonuclear leukocyte chemotaxis.
    Schröder JM; Christophers E
    Immunobiology; 1983 Mar; 164(2):127-35. PubMed ID: 6852861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergism between zymosan-activated serum and heparin in the induction of polymorphonuclear leukocyte aggregation.
    Berliner S; Fishelson Z; Wasserman L; Pinkhas J; Aronson M
    Biomed Pharmacother; 1988; 42(1):69-72. PubMed ID: 3408808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Klinokinesis in polymorphonuclear leucocytes.
    Keller HU; Meier G; Zimmerman A
    Blood Cells; 1984; 10(2-3):505-9. PubMed ID: 6543663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible neutrophil aggregation. A mechanism of decreased newborn neutrophil chemotactic response.
    Mease AD; Burgess DP; Thomas PJ
    Am J Pathol; 1981 Jul; 104(1):98-102. PubMed ID: 7258298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte dysfunction in severe trauma: evidence for the role of C5a in deactivation.
    Antrum RM; Solomkin JS
    Surgery; 1986 Jul; 100(1):29-37. PubMed ID: 3726758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wheat germ agglutinin specifically inhibits formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
    Perez HD; Ong R; Khanna K; Banda D; Goldstein IM
    J Immunol; 1982 Dec; 129(6):2718-24. PubMed ID: 6897258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of HIV polymorphonuclear leukocyte transmigration across T84 cell monolayers: an alternative mechanisms for increased intestinal bacterial infections in AIDS?
    Hofman P; Fischer F; Far DF; Selva E; Battaglione V; Bayle J; Rossi B
    Eur Cytokine Netw; 1999 Sep; 10(3):373-82. PubMed ID: 10477394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects in serum attractant activity in different types of chronic liver disease.
    Yousif-Kadaru AG; Rajkovic IA; Wyke RJ; Williams R
    Gut; 1984 Jan; 25(1):79-84. PubMed ID: 6690377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alpha 1-proteinase inhibitor on chemotaxis and chemokinesis of polymorphonuclear leukocytes: its possible role in regulating polymorphonuclear leukocyte recruitment in human subjects.
    Aoshiba K; Nagai A; Ishihara Y; Kagawa J; Takizawa T
    J Lab Clin Med; 1993 Sep; 122(3):333-40. PubMed ID: 8409709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy.
    Mendonça MA; Cunha FQ; Murta EF; Tavares-Murta BM
    Cancer Chemother Pharmacol; 2006 May; 57(5):663-70. PubMed ID: 16133528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
    Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA
    Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low-density lipoproteins on polymorphonuclear leukocyte functions in vitro.
    Bonneau C; Couderc R; Roch-Arveiller M; Giroud JP; Raichvarg D
    J Lipid Mediat Cell Signal; 1994 Sep; 10(3):203-12. PubMed ID: 7812672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of leucocyte-associated chemotaxin C5a correlate with the mobilisation of polymorphonuclear leucocytes during operations for rectal cancer.
    Johnson E; Langeggen H; Hetland G
    Eur J Surg; 2000 Feb; 166(2):159-64. PubMed ID: 10724495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.